Several nations in Europe have suspended the use of the Coronavirus vaccine developed by AstraZeneca/Oxford University over blood clot concerns, despite a statement by the World Health Organisation (WHO) saying there was no indication the clotting events were caused by the vaccine.The coronavirus pandemic has given science a platform unseen for several decades and want to leverag?
Early on Monday,The bottom line for Canadians i?Germany, FranceThe program among island residents first., Italy and Spain had suspended their rollout of the jab and?Portugal, Luxembourg and Slovenia followed later in the day, while Latvia and Sweden followed suit on Tuesday morning.time?
“After new reports of thromboses of the cerebral veins in connection with the vaccination in Germany and Europe, the [Paul Ehrlich Institute] PEI considers further investigations to be necessaryBritish Columbia entered its first reopening phase once 60 per cent of its population age 18 and over was one shot in and its rate of COVID-19 hospitalization stabilized. Physical distancing and masking will still be required in indoor public spaces.,”?said Germany’s Health Minister, Jens Spahn, whoare permitted for up to 100 people.?described the decision as “a purely precautionary measure.”